Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-SES-PAD Trial: NMES plus heparin-augmented exercise in peripheral artery disease
jRCT1032250268Recruiting
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Aug 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of heparin in arteriosclerosis obliterans (2 arms), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Maximal walking time/distance at 14 days. Started Aug 2025; status: recruiting.
02
Drugs
heparin
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on jRCT1032250268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1032250268.